Literature DB >> 8875758

Graves' disease occurring after subacute thyroiditis: report of a case and review of the literature.

L Bartalena1, F Bogazzi, F Pecori, E Martino.   

Abstract

A 57-year-old woman with no previous personal or family history of thyroid disease developed typical subacute thyroiditis, with pain and tenderness in the anterior cervical region, fever, mild thyrotoxicosis; thyroid autoantibodies were negative, serum thyroglobulin (TG) levels were increased, radioactive iodine uptake (RAIU) values were decreased, urinary iodine excretion was normal, and erythrocyte sedimentation rate (ESR) elevated. Symptoms subsided with glucocorticoid treatment, with normalization of serum thyroid hormone and TG levels. Four months later, while still on a low dose of glucocorticoid, she had recurrence of hyperthyroidism, with no thyroid pain or tenderness, high RAIU values, positive thyroid-directed autoantibodies including TSH-receptor antibody. HLA typing showed positivity for B35 and DR3, suggesting a genetic susceptibility for both subacute thyroiditis and Graves' disease. The development of Graves' disease after subacute thyroiditis is extremely rare, suggesting that a genetic susceptibility to the disease must exist in such an instance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875758     DOI: 10.1089/thy.1996.6.345

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

1.  Incidence of radiation-induced Graves' disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay.

Authors:  Simone Dunkelmann; Ricarda Wolf; Annedore Koch; Christian Kittner; Peter Groth; Carl Schuemichen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-19       Impact factor: 9.236

2.  Graves' hyperthyroidism and ophthalmopathy associated with pemphigus vulgaris: onset of thyroid autoimmune disease during chronic low-dose glucocorticoid therapy.

Authors:  L Bartalena; F Bogazzi; L Chiovato; M L Tanda; E Martino
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

3.  Graves' disease and thyroid associated ophthalmopathy triggered by 131I treatment of non-toxic goiter.

Authors:  B Nygaard; R A Metcalfe; J Phipps; A P Weetman; L Hegedüs
Journal:  J Endocrinol Invest       Date:  1999-06       Impact factor: 4.256

4.  Thyroglobulin autoantibodies of patients with subacute thyroiditis are restricted to a major B cell epitope.

Authors:  F Latrofa; D Ricci; L Montanelli; M A Altea; A Pucci; A Pinchera; P Vitti
Journal:  J Endocrinol Invest       Date:  2012-09       Impact factor: 4.256

5.  Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?

Authors:  Hooshang Lahooti; Kishan R Parmar; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2010-05-14

6.  Extent of hypoechogenic area in the thyroid is related with thyroid dysfunction after subacute thyroiditis.

Authors:  E Nishihara; N Amino; H Ohye; H Ota; M Ito; S Kubota; S Fukata; A Miyauchi
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

7.  Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report.

Authors:  Bengt Hallengren; Tereza Planck; Peter Åsman; Mikael Lantz
Journal:  Eur Thyroid J       Date:  2015-07-18

8.  Strong Correlation between HLA and Clinical Course of Subacute Thyroiditis-A Report of the Three Siblings.

Authors:  Magdalena Stasiak; Andrzej Lewiński
Journal:  Genes (Basel)       Date:  2020-10-29       Impact factor: 4.096

9.  Graves Disease Following Subacute Thyroiditis in a Chinese Man.

Authors:  Souad Al-Bacha; Sharon Wu Lahiri
Journal:  AACE Clin Case Rep       Date:  2021-10-20

10.  Graves' Disease Presenting as Painful Goiter: A Case Report and Review of the Literature.

Authors:  Amir Shahbaz; Kashif Aziz; Muhammad Umair; Mohaddeseh Sharifzadeh; Issac Sachmechi
Journal:  Cureus       Date:  2018-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.